How Infection Spreads in Germ Theory

Pathophysiology Essays

Q1

Question 1: Comparison of Virus and Bacteria in Terms of Infection and the Body's Response

a. Basic Chemical, Molecular, and Cellular Mechanisms of Infection for Viruses and Bacteria

Viruses and bacteria differ in their structure and mechanisms of infection (Rogers, 2020). Viruses are smaller and simpler than bacteria, and consist of genetic material (either DNA or RNA) encased within a protein coat (capsid). Some viruses also have an outer lipid envelope. Viruses cannot reproduce independently; they require a host cell to replicate. The theory is that the virus injects its genetic material into the host cell, thus hijacking the host to produce viral proteins and replicate viral particles. A fully assembled viral particle is called a virion (Rogers, 2020).

Viruses can be classified based on their genetic material into DNA viruses and RNA viruses. DNA viruses integrate their DNA into the host cell’s genome. RNA viruses use the host’s ribosomes to translate viral RNA into proteins. Some RNA viruses, such as retroviruses, reverse-transcribe their RNA into DNA, which then integrates into the host genome (Rogers, 2020).

Bacteria are single-celled prokaryotes that can live and reproduce independently. They have a more complex structure with a rigid cell wall, a plasma membrane, and cytoplasm containing DNA, ribosomes, and various enzymes necessary for metabolic processes. Bacteria can infect the host by releasing toxins or invading tissues. Some bacteria, like Gram-positive and Gram-negative bacteria, have different cell wall structures that influence how they interact with the host and how susceptible they are to antibiotics.

b. Mechanisms of Damage to the Human Body

Viruses cause damage by directly invading and destroying host cells. The viral life cycle involves the virus entering the host cell, taking over its machinery, and replicating within the cell. This often leads to the lysis (bursting) of the cell as new virions are released to infect additional cells. The damage caused by viruses can lead to inflammation, cell death, and the disruption of normal cellular functions. For example, viruses like influenza target respiratory cells, while HIV attacks immune cells, leading to immunodeficiency (“Microbiology and Infectious Disease”, n.d.).

Bacteria, on the other hand, damage the body through several methods, including the release of exotoxins and endotoxins. Exotoxins are potent, secreted toxins that can disrupt cellular functions, while endotoxins are components of the bacterial cell wall that trigger strong inflammatory responses when the bacteria are lysed. Bacteria can also invade and colonize tissues, creating localized infections like abscesses or spreading systemically through the bloodstream, causing conditions like sepsis. For instance, Staphylococcus aureus can produce toxins that cause toxic shock syndrome, while Escherichia coli can release endotoxins leading to severe diarrhea and kidney damage (“Microbiology and Infectious Disease”, n.d.).

c. Internal Cellular and Molecular Mechanisms Used by the Human Body to Eliminate Microorganisms

For viruses, the body primarily relies on cytotoxic T cells and natural killer (NK) cells. Once a virus infects a host cell, viral proteins are displayed on the cell surface through major histocompatibility complex (MHC) class I molecules. Cytotoxic T cells recognize these viral peptides and destroy the infected cell to prevent the virus from replicating. Interferons, which are signaling proteins produced by infected cells, play a critical role in alerting neighboring cells to the presence of a virus, enhancing their antiviral defenses. NK cells can also target and destroy infected cells by recognizing abnormal surface markers (Rogers, 2020).

For bacteria, the immune system uses several mechanisms. Phagocytosis, carried out by macrophages and neutrophils, is a key process. These immune cells engulf and digest bacteria using enzymes contained in their lysosomes. The immune system also produces antibodies that specifically bind to bacterial antigens, marking them for destruction in a process called opsonization. The complement system can lyse bacterial cells by creating pores in their membranes, particularly targeting bacteria that are not efficiently phagocytosed. Helper T cells aid the immune response by activating macrophages and promoting antibody production by B cells (Rogers, 2020).

Q2

The innate immune system is the body's first responder against foreign invaders. Inflammation is a component of innate immunity, and is brought about by the presence of pathogens or tissue damage. When a pathogen breaches the skin or mucous barriers, pattern recognition receptors on immune cells (macrophages, neutrophils, and dendritic cells) recognize pathogen-associated molecular patterns. This recognition prompts the inflammatory response (Rogers, 2020).

Key Cells

Neutrophils are the first responders to infection; they go to the site of infection and destroy pathogens. Macrophages are phagocytic cells that engulf and digest pathogens. They also release cytokines to amplify inflammation and recruit other immune cells to the site of infection. Dendritic cells bridge the innate and adaptive systems by capturing antigens and presenting them to T cells to activate the adaptive response (Rogers, 2020).

Key Chemicals

Cytokines (for example, interleukins or tumor necrosis factor-alpha) are proteins that mediate the inflammatory response by promoting vasodilation and increasing vascular permeability, which lets immune cells to access the infected tissue. Histamine is released by mast cells to increase blood flow and the permeability of capillaries, which supports the migration of immune cells to the infection site.

Speed of Action

The innate immune response is rapid, occurring within minutes to hours of infection. It does not require prior exposure to a pathogen and is not pathogen-specific.

Desired Outcome

The primary goal of the innate immune response is to contain and eliminate pathogens before they spread. It also initiates the repair of damaged tissues and sets the stage for the adaptive immune response if needed.

Adaptive Immunity: Acquired (Third Line of Defense)

The adaptive immune system is slower to respond but provides specific and long-lasting protection against pathogens. It is activated when innate immunity is insufficient to eliminate the threat. Adaptive immunity relies on lymphocytes, which include B cells and T cells, and its function is to recognize and remember specific antigens through antigen presentation and the production of antibodies (“Adaptive Immunity System Physiology”, n.d.).

Key Cells

When activated by an antigen, B cells differentiate into plasma cells that produce antibodies. These antibodies neutralize pathogens or mark them for destruction. Additionally, there are two main types of T cells—helper T cells (CD4+) and cytotoxic T cells (CD8+). Helper T cells stimulate both B cells and cytotoxic T cells; cytotoxic T cells directly kill infected cells.

Key Chemicals

Antibodies are produced by B cells and bind specifically to antigens on pathogens, and neutralize them or mark them for destruction by other immune cells. Plus, adaptive immunity also uses cytokines, such as interferons and interleukins, to regulate immune cell function.

Speed of Action

The adaptive immune response is slower, and takes days to weeks to fully activate after initial exposure to a pathogen. However, it is specific to the invading pathogen and has the ability to form memory cells, which allow for a faster and more robust response upon subsequent encounters (“Adaptive Immunity System Physiology”, n.d.).

Desired Outcome

The goal of adaptive immunity is to eradicate specific pathogens and develop immunological memory, ensuring that future infections by the same pathogen are dealt with more efficiently.

Overlap and Communication Between the Systems

The innate and adaptive immune systems are distinct, but they are also highly interconnected. Dendritic cells, for instance, are part of the innate system but play a pivotal role in activating the adaptive system by presenting antigens to T cells. Cytokines produced during innate immunity can also influence the activation and differentiation of B and T cells in the adaptive response (Rogers, 2020).

Both systems work to eliminate pathogens, but they differ in their mechanism of action. The innate immune system responds quickly and non-specifically to contain the infection. The adaptive immune system provides a slower, highly specific response with the added benefit of long-term immunity through memory cells (“Innate Immunity: Inflammation,” n.d.).

Q3

The first step in the antibody-mediated immune response is the recognition of antigens. Antigens are molecules, usually proteins or polysaccharides, found on the surface of pathogens such as bacteria, viruses, and toxins. When a pathogen enters the body, B cells with membrane-bound antibodies, or B cell receptors (BCR), circulate in the bloodstream and lymphatic system, looking for their specific antigen. Each antibody or BCR is highly specific to a particular antigen due to the unique structure of its variable region, where antigen binding occurs. This region contains hypervariable loops that form the antigen-binding site, allowing the antibody to fit precisely with its corresponding antigen, similar to a lock and key. Once the B cell receptor binds to an antigen, the B cell is activated (Rogers, 2020). Once B cells are activated, they proliferate and differentiate into plasma cells that secrete antibodies. These antibodies are released into the bloodstream and lymphatic system, where they seek out and neutralize pathogens (Rogers, 2020).

Antibodies can block the activity of pathogens by binding to the surface of viruses or bacterial toxins. For example, when antibodies coat the surface of a virus, they prevent it from binding to host cell receptors, thereby neutralizing its ability to infect cells (Rogers, 2020). Antibodies can also mark pathogens for destruction through a process called opsonization, where they bind to the surface of pathogens, effectively "tagging" them for recognition by phagocytic cells such as macrophages and neutrophils (Rogers, 2020). Antibodies can also trigger the complement system, i.e. proteins in the blood that assist in destroying pathogens (Rogers, 2020).

Humoral immunity, which is mediated by antibodies produced by B cells, is the main defense against extracellular pathogens such as bacteria and viruses in their free-floating forms. The humoral response works by neutralizing pathogens before they can enter cells. Circulating antibodies bind to antigens, neutralize them, and facilitate their removal through phagocytosis or complement-mediated destruction (Rogers, 2020).

Cell-mediated immunity uses T cells instead of antibodies. However, helper T cells (Th cells) help to activate B cells to produce antibodies in the first place. Cytotoxic T cells target and destroy infected cells by recognizing antigens, which is important when it comes to intracellular pathogens because antibodies alone cannot reach these once they have infected a cell (Rogers, 2020).

Thus, cell-mediated immunity does not involve antibodies directly, but it works with humoral immunity to clear infections. For example, antibodies can mark infected cells for destruction by cytotoxic T cells or natural killer cells through a process called antibody-dependent cellular cytotoxicity (Rogers, 2020).

The ultimate goal of the antibody response is the complete elimination of the pathogen. Once antibodies have neutralized pathogens, marked them for destruction through opsonization, or activated the complement system, immune cells ingest and destroy the pathogens. Memory B cells formed during the immune response make it so that future encounters with the same pathogen are met with a more rapid and effective immune response.

Q4

Table: Sympathetic and Parasympathetic Innervation of Selected Tissues and Functions

Tissue/Function

Sympathetic Receptor Type

Parasympathetic Receptor Type

Sympathetic NT

Parasympathetic NT

Sympathetic Response

Parasympathetic Response

a. Heart

?1 (beta-1)

M2 (muscarinic)

Norepinephrine

Acetylcholine

Increased heart rate and force of contraction (positive inotropic and chronotropic effects)

Decreased heart rate and contractility (negative inotropic and chronotropic effects)

b. Coronary Arteries

?1 (alpha-1), ?2 (beta-2)

None significant

Norepinephrine

None

?1: Vasoconstriction; ?2: Vasodilation

No significant parasympathetic response

c. Peripheral Arteries

?1 (alpha-1)

None significant

Norepinephrine

None

Vasoconstriction

No significant parasympathetic response

d. Veins

?1 (alpha-1), ?2 (alpha-2)

None significant

Norepinephrine

None

?1 and ?2: Vasoconstriction

No significant parasympathetic response

e. Bronchial Tube Smooth Muscle

?2 (beta-2)

M3 (muscarinic)

Epinephrine

Acetylcholine

Relaxation (bronchodilation)

Constriction (bronchoconstriction)

f. GI Motility

?1 (alpha-1), ?2 (beta-2)

M3 (muscarinic)

Norepinephrine

Acetylcholine

Decreased motility (smooth muscle relaxation)

Increased motility (smooth muscle contraction)

g. GI Secretions

None significant

M3 (muscarinic)

None

Acetylcholine

No significant sympathetic effect

Increased secretions (enhanced digestive enzyme and mucus secretion)

Explanation of Key Points

a. Heart

The heart is innervated by ?1 adrenergic receptors, which respond to norepinephrine and lead to increased heart rate (positive chronotropy) and force of contraction (positive inotropy) when activated. This allows the body to increase cardiac output in response to stress or exercise (Rogers, 2020).

The parasympathetic system primarily uses M2 muscarinic receptors, which are stimulated by acetylcholine. This results in a decrease in heart rate (negative chronotropy) and reduced contractility (negative inotropy), helping to conserve energy during rest (Sullivan et al., 2023).

b. Coronary Arteries

With sympathetic innervation, ?1 adrenergic receptors and ?2 adrenergic receptors are involved. ?1 receptors cause vasoconstriction, which helps redirect blood flow, while ?2 receptors mediate vasodilation, particularly under the influence of circulating epinephrine, ensuring increased blood supply during stress or physical activity (Rogers, 2020).

With parasympathetic innervation, there is no significant parasympathetic innervation to the coronary arteries, so there is minimal direct effect.

c. Peripheral Arteries

Mainly mediated by ?1 adrenergic receptors, sympathetic stimulation leads to vasoconstriction of peripheral arteries, especially in the skin and gastrointestinal tract, which helps redirect blood flow to essential organs like the heart and muscles during stress.

There is no significant parasympathetic innervation of peripheral arteries.

d. Veins

For sympathetic innervation, ?1 and ?2 adrenergic receptors mediate venoconstriction, which helps increase venous return to the heart, thereby supporting cardiac output during sympathetic activation.

There is no significant parasympathetic regulation of venous tone.

e. Bronchial Tube Smooth Muscle

For sympathetic innervation, ?2 adrenergic receptors are responsible for bronchodilation, allowing increased airflow during sympathetic stimulation, such as during exercise or a fight-or-flight response (Rogers, 2020).

For, parasympathetic innervation, the M3 muscarinic receptors, when activated by acetylcholine, cause bronchoconstriction, reducing airflow as part of the body's resting state.

f. GI Motility

For sympathetic innervation, ?1 and ?2 adrenergic receptors lead to decreased gastrointestinal motility by causing smooth muscle relaxation. This response conserves energy and redirects blood flow away from the digestive tract during times of stress.

For parasympathetic innervation, M3 muscarinic receptors enhance gastrointestinal motility by promoting smooth muscle contraction, which is crucial for digestion and peristalsis during rest (Rogers, 2020).

g. GI Secretions

There is no significant sympathetic regulation of gastrointestinal secretions.

For parasympathetic innervation, the M3 muscarinic receptors cause an increase in gastrointestinal secretions, including digestive enzymes and mucus, supporting the digestive process (Brunton & Knollmann, 2023).

Q5

Psychotic disorders like schizophrenia and major depression involve pathophysiologies that are not fully understood, but both are believed to be influenced by neurotransmitter imbalances. These disorders share some similarities in symptoms and treatment, but they also differ in terms of underlying mechanisms, clinical manifestations, and outcomes.

a. Etiology

Schizophrenia and major depression involve a combination of genetic, environmental, and biochemical factors. Schizophrenia is believed to have a strong genetic component, with studies suggesting that individuals with a family history of schizophrenia are at higher risk of developing the disorder. Environmental factors (prenatal exposure to infections, stress) as well as psychosocial factors, may also be factors. In addition, cannabis use during adolescence has been linked to an increased risk of schizophrenia in genetically predisposed individuals (Psychiatric Disorders, n.d.).

Major depression also has genetic and environmental components, but the specific triggers often include psychosocial stressors such as trauma, loss, and chronic stress. Unlike schizophrenia, which tends to manifest in early adulthood, major depression can arise at any age, often triggered by significant life events. Hormonal imbalances, such as those related to pregnancy or thyroid dysfunction, may also play a role in depression (Rogers, 2020).

b. Pathophysiology

At the cellular and molecular level, schizophrenia and major depression are associated with neurotransmitter imbalances, but the affected systems and the mechanisms differ.

Schizophrenia is associated with abnormalities in dopamine signaling (Rogers, 2020). The dopamine hypothesis is that hyperactivity of dopamine in the mesolimbic pathway contributes to positive symptoms, i.e., hallucinations and delusions; reduced dopamine activity in the prefrontal cortex contributes to negative symptoms such as social withdrawal and cognitive deficits (Rogers, 2020). In addition to dopamine, alterations in glutamate and GABA (gamma-aminobutyric acid) signaling have been associated with the cognitive and negative symptoms of schizophrenia (Psychiatric Disorders, n.d.; Rogers, 2020).

Major depression is associated with dysregulation of serotonin, norepinephrine, and dopamine (Rogers, 2020). The monoamine hypothesis of depression suggests that a deficiency in these neurotransmitters leads to depressive symptoms, although this theory has evolved to include disruptions in neuroplasticity and stress-related pathways. Chronic stress and elevated levels of cortisol can impair hippocampal neurogenesis and contribute to mood disturbances (Nervous System, n.d.).

Both disorders involve neurotransmitter imbalances, but schizophrenia is more strongly linked to dopamine dysregulation, and depression involves a range of neurotransmitters, such as serotonin and norepinephrine (“Degenerative and Cognitive Disorders”, n.d.).

c. Clinical Manifestations

Schizophrenia is characterized by positive symptoms (hallucinations, delusions, and disorganized thinking), negative symptoms (social withdrawal, flat affect, and lack of motivation), and cognitive impairments (difficulty with attention, memory, and executive functioning). The positive symptoms are more noticeable in the acute phase, while negative symptoms and cognitive deficits are often persistent and debilitating (Psychiatric Disorders, n.d.).

Major depression is primarily marked by persistent low mood, anhedonia (loss of interest in activities), feelings of worthlessness, and fatigue. Cognitive symptoms such as impaired concentration are common, but unlike schizophrenia, psychotic features (e.g., hallucinations or delusions) are not always present. When they do occur, they are usually mood-congruent, meaning they align with the depressive themes of guilt, worthlessness, or death (Rogers, 2020).

While schizophrenia presents with both positive and negative symptoms, major depression is primarily characterized by mood disturbances. Schizophrenia's cognitive impairments are more severe and long-lasting, and depression’s cognitive deficits tend to be less prominent and more reversible with treatment (Psychiatric Disorders, n.d.).